G. Ramamoorthy et al. / Tetrahedron: Asymmetry 19 (2008) 2546–2554
2553
(m, 6H), 1.49 (s, 3H), 1.39 (m, 1H), 1.30 (t, 3H, J = 7.2 Hz), 1.26 (m,
1H), 0.97 (d, 3H, J = 6.6 Hz), 0.87 (t, 3H, J = 7.2 Hz); 13C NMR
(75 MHz, CDCl3) d 172.6, 141.3, 138.7, 130.1, 121.4, 120.0, 83.7,
80.7, 61.4, 38.4, 37.2, 34.8, 30.5, 24.1, 23.4, 22.3, 21.0, 17.0, 14.5,
12.4; HRMS calcd 336.2301, found 336.2306; IR (CHCl3) mmax
3H); 13C NMR (75 MHz, CDCl3) d 175.5, 140.2, 138.7, 131.0,
124.2, 77.2, 72.1, 62.5, 34.7, 30.5, 22.8, 20.9, 16.7, 14.4, 12.3; HRMS
calcd 270.1831, found 270.1832; IR (CH2Cl2) mmax 3466, 2962,
2925, 2873, 1731, 1455, 1375, 1247, 1117, 1018 cmꢀ1
.
2960, 2868, 1749, 1732, 1456, 1374, 1337, 1233, 1106, 1024 cmꢀ1
.
4.15. Methyl N-[(2R,3S,4Z,6E,8S)-2,3-dihydroxy-2,6,8-
trimethyldeca-4,6-dienoyl]glycinate (RSS)-14
4.11. Ethyl (2R,3S,4Z,6E,8S)-2,3-dihydroxy-2,6,8-trimethyldeca-
4,6-dienylcarboxylate (RSS)-13
To a solution of 13 (65 mg, 0.24 mmol) in 1:1 MeOH–THF
(700
(300
l
L) was added a solution of LiOH (65 mg, 1.53 mmol) in water
To a solution of 12 (150 mg, 0.45 mmol) in 1:1 MeOH–CH2Cl2
(2 mL) was added 10-camphorsulfonic acid (20 mg, 0.09 mmol)
and the reaction mixture was stirred for 24 h at 25 °C. The reaction
was concentrated in vacuo and diluted with EtOAc (5 mL). The or-
ganic layer was washed with satd NaHCO3(aq) (1ꢂ), water (2ꢂ) and
brine (1ꢂ), dried over Na2SO4, and concentrated under reduced
pressure. The crude product was purified by flash column chroma-
tography (25% EtOAc/hexanes) to afford 13 (75 mg, 63%) as a color-
lL) at 25 °C and the reaction mixture was stirred for 3 h.
(Note: The (2R,3R,8S)- and (2S,3S,8S)-isomers needed 24 h for con-
sumption of the starting material). The reaction mixture was con-
centrated in vacuo, diluted with water and acidified to pH 2 with
2 M HCl. The aqueous solution was extracted with EtOAc (3ꢂ)
and the combined organic layer was washed with water, dried over
Na2SO4, and concentrated in vacuo. The crude acid was carried on
to the next step without further purification.
To a stirred solution of the crude acid, HOBt (48 mg, 0.31
mmol), glycine methyl ester hydrochloride (47 mg, 0.37 mmol),
and diisopropylethylamine (430 lL, 3.10 mmol) in anhydrous
less oil. ½a 2D5
ꢃ
¼ ꢀ80:1 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) d
6.14 (d, 1H, J = 11.7 Hz), 5.43 (dd, 1H, J = 9.9, 11.7 Hz), 5.24 (d,
1H, J = 9.9 Hz), 4.79 (d, 1H, J = 9.9 Hz), 4.38 (m, 2H), 3.46 (br s,
1H), 2.33 (m, 1H), 1.76 (d, 3H, J = 0.9 Hz), 1.38 (m, 1H), 1.28 (t,
3H, J = 7.2 Hz), 1.27 (s, 3H), 1.25 (m, 1H), 0.95 (d, 3H, J = 6.6 Hz),
0.85 (t, 3H, J = 7.5 Hz); 13C NMR (75 MHz, CDCl3) d 176.5, 139.0,
138.6, 124.7, 77.3, 62.5, 34.7, 30.5, 22.6, 20.9, 17.0, 14.4, 12.4;
HRMS calcd 270.1831, found 270.1828; IR (CH2Cl2) mmax 3489,
CH2Cl2 (1.5 mL) was added EDCI (71 mg, 0.37 mmol) at 25 °C and
the reaction mixture was stirred for 12 h. The reaction mixture
was diluted with CH2Cl2 (5 mL) and washed with 0.5 M HCl (2ꢂ),
water (1ꢂ), and brine (1ꢂ). The organic layer was dried over
Na2SO4 and concentrated in vacuo. The crude product was purified
by flash column chromatography (60% EtOAc/hexanes) to afford 14
2962, 2925, 2855, 1736, 1456, 1377, 1251, 1118, 1019 cmꢀ1
.
(62 mg, 82%) as a colorless, viscous oil. ½a D25
¼ ꢀ16:8 (c 2.5, CHCl3);
ꢃ
4.12. Ethyl (2R,3R,4Z,6E,8S)-2,3-dihydroxy-2,6,8-trimethyldeca-
4,6-dienylcarboxylate (RRS)-13
1H NMR (400 MHz, CD3OD) d 6.11 (d, 1H, J = 11.9 Hz), 5.44 (dd, 1H,
J = 10.4, 11.6 Hz), 5.27 (d, 1H, J = 9.6 Hz), 4.85 (d, 1H, J = 10.3 Hz),
3.98 (AB, 2H, JAB = 17.8 Hz,
DAB = 68.6 Hz), 3.72 (s, 3H), 2.36 (m,
Prepared by the same procedure used to make (RSS)-13.
1H), 1.80 (br s, 3H), 1.39 (m, 1H), 1.28 (m, 1H), 1.24 (s, 3H), 0.97
(d, 3H, J = 6.8 Hz), 0.87 (t, 3H, J = 7.3 Hz); 13C NMR (100 MHz,
CD3OD) d 178.9, 171.8, 139.4, 138.5, 132.2, 126.5, 78.6, 72.2,
52.6, 41.8, 35.6, 31.4, 23.2, 21.1, 17.0, 12.5; HRMS calcd
314.1967, found 314.1965; IR (CH2Cl2) mmax 3379, 2959, 2929,
½
a 2D5
ꢃ
¼ þ44:7 (c 1.1, CHCl3); 1H NMR (300 MHz, CDCl3) d 6.05 (d,
1H, J = 11.7 Hz), 5.38 (d, 1H, J = 10.2 Hz), 5.32 (dd, 1H, J = 10.2,
12.6 Hz), 4.62 (d, 1H, J = 9.9 Hz), 4.20 (m, 2H), 3.46 (br s, 1H),
2.32 (m, 1H), 1.79 (d, 3H, J = 1.2 Hz), 1.46 (s, 3H), 1.36 (m, 1H),
1.28 (m, 1H), 1.26 (t, 3H, J = 7.2 Hz), 0.95 (d, 3H, J = 6.6 Hz), 0.86
(t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 175.5, 139.9, 138.8,
130.9, 124.3, 77.1, 72.2, 62.5, 34.7, 30.6, 22.8, 20.9, 16.8, 14.4,
12.4; HRMS calcd 270.1831, found 270.1830; IR (CH2Cl2) mmax
2872, 1744, 1655, 1528, 1451, 1439, 1370, 1214, 1020 cmꢀ1
.
4.16. Methyl N-[(2R,3R,4Z,6E,8S)-2,3-dihydroxy-2,6,8-
trimethyldeca-4,6-dienoyl]glycinate (RRS)-14
3438, 2962, 2927, 2866, 1729, 1599, 1452, 1247, 1119, 1018 cmꢀ1
.
The procedure for making (RSS)-14 was followed, except that the
4.13. Ethyl (2S,3R,4Z,6E,8S)-2,3-dihydroxy-2,6,8-trimethyldeca-
4,6-dienylcarboxylate (SRS)-13
saponification required 12 h to reach completion. ½a D25
¼ þ38:5 (c
ꢃ
3.75, CHCl3); 1H NMR (400 MHz, CD3OD) d 8.14 (br s, 1H), 5.97 (d,
1H, J = 11.8 Hz), 5.52 (dd, 1H, J = 10.1, 11.8 Hz), 5.27 (d, 1H,
J = 9.5 Hz), 4.63 (d, 1H, J = 10.1 Hz), 3.97 (m, 1H), 3.71 (m, 1H), 3.71
(s, 3H), 2.34 (m, 1H), 1.77 (br s, 3H), 1.39 (s, 3H), 1.38 (m, 1H), 1.28
(m, 1H), 0.97 (d, 3H, J = 6.5 Hz), 0.88 (t, 3H, J = 7.4 Hz); 13C NMR
(100 MHz, CD3OD) d 177.8, 171.7, 139.1, 138.2, 132.4, 126.4, 78.5,
72.7, 52.6, 41.6, 35.5, 31.5, 23.1, 21.0, 16.7, 12.5; HRMS calcd
314.1967, found 314.1968; IR (CH2Cl2) mmax 3395, 2956, 2925,
Prepared by the same procedure used to make (RSS)-13.
½
a 2D5
ꢃ
¼ þ110:4 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) d 6.15 (d,
1H, J = 11.7 Hz), 5.46 (dd, 1H, J = 9.9, 11.7 Hz), 5.26 (d, 1H,
J = 9.9 Hz), 4.79 (d, 1H, J = 9.9 Hz), 4.26 (q, 2H, 7.5 Hz), 3.46 (br s,
1H), 2.34 (m, 1H), 1.76 (d, 3H, J = 1.2 Hz), 1.38 (m, 1H), 1.29 (t,
3H, J = 7.2 Hz), 1.27 (s, 3H), 1.26 (m, 1H), 0.97 (d, 3H, J = 6.6 Hz),
0.87 (t, 3H, J = 7.5 Hz); 13C NMR (75 MHz, CDCl3) d 176.5, 139.2,
138.4, 130.7, 124.7, 77.2, 71.9, 62.5, 34.7, 30.6, 22.6, 21.0, 17.0,
14.4, 12.4; HRMS calcd 270.1831, found 270.1834; IR (CH2Cl2) mmax
3467, 2961, 2925, 2868, 1735, 1456, 1375, 1250, 1176, 1117,
2873, 1747, 1656, 1530, 1450, 1439, 1367, 1210, 1183, 1013 cmꢀ1
.
4.17. Methyl N-[(2S,3R,4Z,6E,8S)-2,3-dihydroxy-2,6,8-
trimethyldeca-4,6-dienoyl]glycinate (SRS)-14
1018 cmꢀ1
.
The procedure for making (RSS)-14 was followed. ½a D25
¼ þ55:0 (c
ꢃ
4.14. Ethyl (2S,3S,4Z,6E,8S)-2,3-dihydroxy-2,6,8-trimethyldeca-
4,6-dienylcarboxylate (SSS)-13
1.0, CHCl3); 1H NMR (400 MHz, CD3OD) d 6.11 (d, 1H, J = 11.8 Hz),
5.44 (dd, 1H, J = 10.4, 11.6 Hz), 5.28 (d, 1H, J = 9.6 Hz), 4.84 (d, 1H,
J = 10.3 Hz), 4.00 (AB, 3H, JAB = 17.8 Hz,
D AB = 68.6 Hz), 3.72 (s,
Prepared by the same procedure used to make (RSS)-13.
3H), 2.36 (m, 1H), 1.80 (br s, 3H), 1.39 (m, 1H), 1.29 (m, 1H), 1.23
(s, 3H), 0.97 (d, 3H, J = 6.6 Hz), 0.89 (t, 3H, J = 7.4 Hz); 13C NMR
(100 MHz, CD3OD) d 178.9, 171.8, 139.3, 138.6, 132.1, 126.5, 78.6,
72.3, 52.6, 41.8, 35.6, 31.4, 23.2, 21.1, 16.9, 12.5; HRMS calcd
314.1967, found 314.1966; IR (CH2Cl2) mmax 3395, 2959, 2930,
½
a 2D5
ꢃ
¼ þ3:4 (c 1.25, CHCl3); 1H NMR (300 MHz, CDCl3) d 6.05 (d,
1H, J = 11.7 Hz), 5.37 (d, 1H, J = 10.2 Hz), 5.32 (d, 1H, J = 10.5 Hz),
4.63 (d, 1H, J = 9.9 Hz), 4.20 (m, 2H), 3.46 (br s, 1H), 2.32 (m, 1H),
1.80 (d, 3H, J = 1.2 Hz), 1.45 (s, 3H), 1.35 (m, 1H), 1.26 (m, 1H),
1.25 (t, 3H, J = 7.2 Hz), 0.97 (d, 3H, J = 6.6 Hz), 0.84 (t, J = 7.5 Hz,
2873, 1746, 1657, 1530, 1452, 1439, 1370, 1215, 1020 cmꢀ1
.